Investigational oral regimen for hepatitis C shows promise in NIH trial National Institutes of Health (press release) More than 3 million Americans have chronic HCV infection, a condition that is a major cause of cirrhosis (liver tissue scarring) and liver cancer, and a leading reason for liver transplantation. Deaths from HCV-related liver disease number about 15,000 ... |
